Drug
Melitracen clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 1
- first study started
- 2014
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2014 (1)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 3
- 1
Who runs them
Industry 2 · Other 1
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses melitracen is read from its arms, and is right about nine times in ten.
Testing it · 3
- Bioequivalence Study to Compare Two Formulations of Deanxit®CompletedPhase 1H. Lundbeck A/SNCT03472651Written as test treatment: flupentixol/melitracen
- Treatment in Patients With Globus: Psychoeducation, Anxiolytics or Proton Pump InhibitorsCompletedPhase 3Mahidol UniversityNCT03205228Written as Flupentixol +Melitracen
- Bioequivalence Study in Healthy Men and Women to Compare Two Pharmaceutical Formulations of Flupentixol/Melitracen (Deanxit®)CompletedPhase 1H. Lundbeck A/SNCT02179931Written as Flupentixol/melitracen film-coated tablet
Codes
What other systems call melitracen · ClinicalTrials.gg INT017655
- UNII (FDA) Q7T0Y1109ZMELITRACENConfirmed FDA, Wikidata
- RxNorm 446248Confirmed FDA, Wikidata
- Wikidata Q411251melitracenConfirmed FDA, Wikidata
- NCI Thesaurus C174875MelitracenOne source FDA
- DrugBank DB13384One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | Q7T0Y1109Z | MELITRACEN | Confirmed FDA, Wikidata |
| RxNorm | 446248 | — | Confirmed FDA, Wikidata |
| Wikidata | Q411251 | melitracen | Confirmed FDA, Wikidata |
| NCI Thesaurus | C174875 | Melitracen | One source FDA |
| DrugBank | DB13384 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.